Oil palm phenolics and vitamin E reduce atherosclerosis in rabbits  by Che Idris, Che Anishas et al.
J O U R N A L O F F U N C T I O N A L F O O D S 7 ( 2 0 1 4 ) 5 4 1 –5 5 0
.sc ienced i rec t .comAvai lab le a t wwwScienceDirect
journal homepage: www.elsevier .com/ locate / j f fOil palm phenolics and vitamin E reduce
atherosclerosis in rabbitshttp://dx.doi.org/10.1016/j.jff.2014.01.002
1756-4646  2014 The Authors. Published by Elsevier Ltd.
* Corresponding author. Tel.: +603 8769 4498; fax: +603 8926 1995.
E-mail address: raviga@mpob.gov.my (R. Sambanthamurthi).
Abbreviations: ABTSÆ+, 2,2 0-azinobis (3-ethylbenzothiazoline) 6-sulphonic acid radical cation; ANOVA, analysis of varia
control; Eo, E-deficient; Fe2+-TPTZ, ferrous-2,4,6-tripyridyl-S-triazine; Fe3+-TPTZ, ferric-2,4,6-tripyridyl-S-triazine; FRAP, ferric
ability of plasma; GAE, gallic acid equivalent; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein c
OPP, oil palm phenolics; RBD, refined, bleached, deodorised; TC, total cholesterol; TE, Trolox equivalent; TG, triglycerides;
significant difference; VIT E, vitamin E.
Open access under  CC BY license.Che Anishas Che Idrisa,b, Tilakavati Karupaiahb, Kalyana Sundramc,
Yew Ai Tana, Nagendran Balasundrama, Soon-Sen Leowa,
Nurrul Shaqinah Nasruddind, Ravigadevi Sambanthamurthia,*
aMalaysian Palm Oil Board, 6, Persiaran Institusi, Bandar Baru Bangi, 43000 Kajang, Selangor, Malaysia
bNational University of Malaysia, Jalan Raja Muda Aziz, 50300 Kuala Lumpur, Malaysia
cMalaysian Palm Oil Council, 2nd Floor, Wisma Sawit, Lot 6, SS6, Jalan Perbandaran, 47301 Kelana Jaya, Selangor, Malaysia
dUniversiti Putra Malaysia, 43400 Serdang, Selangor, MalaysiaA R T I C L E I N F O A B S T R A C TArticle history:
Received 1 April 2013
Received in revised form
24 December 2013
Accepted 3 January 2014
Available online 29 January 2014
Keywords:
Atherosclerosis
Oil palm phenolics
Lipid profiles
Antioxidant activityThe protective effects of oil palm vitamin E and phenolics against atherosclerosis, either
singly or in combination, were studied in an atherogenic rabbit model. Rabbits were either
fed atherogenic diet only (CTR), or atherogenic diet with vitamin E (VIT E), or atherogenic
diet with oil palm phenolics (OPP), or atherogenic diet with both vitamin E and oil palm
phenolics (VIT E + OPP). Results from lipid profile and antioxidant analyses were not signif-
icantly different between groups (p > 0.05). However, fibrous plaques were associated with
the CTR group (8.90 ± 5.41%) and these were significantly less (p < 0.05) in the VIT E
(2.88 ± 2.01%) and OPP (1.48 ± 4.45%) groups. Fibrous plaques were not detected at all in
the VIT E + OPP group. Our findings suggest that oil palm vitamin E and oil palm phenolics
individually inhibited atherosclerotic lesion development. However, oil palm vitamin E in
combination with oil palm phenolics provided the highest protective effect against devel-
opment of atherosclerotic lesions.
 2014 The Authors. Published by Elsevier Ltd.Open access under   license.CC BY1. Introduction
The terms nutraceuticals and functional foods have been
used to describe extracts and whole foods that have the char-
acteristics of providing protective, preventive and possibly
curative effects in the pathogenesis of cancer and other
chronic disease progression. Both nutraceuticals and func-
tional food groups provide benefits beyond what are renderedby their nutrient components (Shahidi, 2005). The oil palm
(Elaeis guineensis) has various functional phytochemicals, thus
making it valuable as a source for the production of nutraceu-
ticals and functional foods (Tan, Sambanthamurthi,
Sundram, & Wahid, 2007).
The presence of several fat-soluble micronutrients in palm
oil such as vitamin E, carotenoids and phytosterols contrib-
utes to its pleiotropic nutritious profile. The oil palm fruitnce; CTR,
reducing
holesterol;
LSD, least
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tochemicals, namely vitamin E (tocopherols and tocotrienols)
and carotenoids, both of which are fat-soluble. Oil palm vita-
min E has been reported to act as a potent biological antioxi-
dant, protecting against oxidative stress and the
atherosclerotic process (Mukherjee & Mitra, 2009; Sundram,
Sambanthamurthi, & Tan, 2003). Recently, oil palm fruits have
also been identified as a rich source of phenolic compounds
(Sambanthamurthi et al., 2011a). A water-soluble extract rich
in phenolic acids has been successfully recovered from the
vegetation liquor generated from the milling of oil palm fruits
(Sambanthamurthi et al., 2011a). These oil palm phenolics
(OPPs) have been found to have antioxidant properties with
potent protective effects against chronic diseases such as car-
diovascular disease, diabetes and cancer, based on studies
with animal models (Sambanthamurthi et al., 2011b).
Oxidation of low-density lipoproteins (LDL-C), the major
cholesterol carrying lipoproteins in plasma is commonly
implicated as an initiator of atherosclerosis. Increased LDL-
C concentration is a major risk factor for atherosclerosis in
humans (Carmena, Duriez, & Fruchart, 2004; Steinbrecher,
Zhang, & Lougheed, 1990). Oxidised LDL-C is engulfed by mac-
rophages, and this rapidly leads to the formation of athero-
sclerotic plaques. The sequential steps in the formation of
foam cells, their rupture into fatty streaks, maturation into
fatty plaques which accumulate in the arterial wall and grad-
ually become fibrous, and their enlargement contributing to
the narrowing of the blood vessel lumen or rupture to form
a thrombus, have been well described by Tedgui and Mallat
(2006). Disruption of blood flow to the heart causing a myocar-
dial infarction or to the brain causing a stroke are the ultimate
events initiated from atherogenic plaque formation (Ross,
1993; Tedgui & Mallat, 2006).
The possible association of atherosclerosis with oxidative
events has led to the hypothesis that dietary antioxidants
may inhibit the development of atherosclerosis and reduce
the incidence of coronary artery disease (Pandey & Rizvi,
2009; Xu et al., 1998). Water-soluble antioxidants (vitamin C,
phenolic compounds including flavonoids) and lipid-soluble
antioxidants (vitamin E, carotenoids) are natural antioxidants
that are hypothesised to have the potential to intervene in the
development of atherosclerosis and cardiovascular disease by
modulating redox sensitive steps in disease progression
(Kinsella, Frankel, German, & Kanner, 1993).
Vitamin E is a generic name for both tocopherols and
tocotrienols. They are structurally similar but tocotrienols dif-
fer from tocopherols in having an unsaturated phytyl side
chain (Colombo, 2010). Both tocopherols and tocotrienols
comprise a, b, c and d forms, depending on the number and
position of methyl groups on the chromanol ring. In total
there are thus eight forms of vitamin E. Both tocopherols
and tocotrienols are recognised for their antioxidative effects
and are suggested to reduce cardiovascular disease by arrest-
ing free radical damage (Stephens et al., 1996; Vasanthi,
Parameswari, & Das, 2012). In this study, we investigated the
effects of palm vitamin E that comprised tocotrienols (70%)
and tocopherols (30%). The nutritional and physiological
properties of vitamin E in palm oil, especially the tocotrienols
are well described by Sundram et al. (2003) and Vasanthi et al.
(2012).In addition to oil palm vitamin E, water-soluble oil palm
phenolics have been shown to have cardioprotective effects.
Sambanthamurthi et al. (2011a) reported that oil palm phen-
olics inhibited copper-mediated oxidation of human LDL-C
in vitro and promoted vascular relaxation in both isolated aor-
tic rings and perfused mesenteric vascular beds pre-con-
tracted with noradrenaline ex vivo. In vivo, oil palm
phenolics reduced blood pressure in a NO-deficient rat model,
protected against ischaemia-induced cardiac arrhythmia in
rats and reduced plaque formation in rabbits fed an athero-
genic diet (Sambanthamurthi et al., 2011b). These findings
suggest that oil palm phenolics have significant biological
activities and may be used as a potential preventative or ther-
apeutic vehicle against atherosclerosis and cardiovascular
disease.
Given that both palm vitamin E (VIT E) and oil palm phen-
olics are individually protective against atherosclerosis devel-
opment in an atherogenic diet-fed rabbit animal model, our
interest therefore was to evaluate these oil palm antioxidants
in combination with each other in the same animal model of
atherosclerosis for potential synergism.
2. Materials and methods
2.1. Animals, diets and experimental design
The animal procedures carried out in this study were ap-
proved by the Animal Care and Use Committee of the Na-
tional University of Malaysia, Kuala Lumpur, Malaysia.
Thirty-two male New ZealandWhite rabbits aged five months
with approximately equal mean body weights were divided
into four different treatment groups of eight animals each.
The animals were housed individually in stainless steel cages
and maintained in a temperature-controlled room (18–23 C)
with a 12-h daylight cycle. All animals were fed ad libitum
on an atherogenic diet for 100 days. Additionally, the animals
were provided with palm vitamin E, oil palm phenolics or a
combination thereof. The experimental groups were classi-
fied as follows:
1. High-Fat Atherogenic Diet Control (CTR)
2. High-Fat Atherogenic Diet + Palm Vitamin E (VIT E)
3. High-Fat Atherogenic Diet + Oil Palm Phenolics (OPP)
4. High-Fat Atherogenic Diet + Palm Vitamin E + Oil Palm
Phenolics (VIT E + OPP)
The high-fat atherogenic diet contained fat at approxi-
mately 35% energy (Table 1) and comprised 72.3% saturated
fatty acids (C12:0 + C14:0 = 54.9%), 15.7% monounsaturated
fatty acids (C18:1) and 12.0% polyunsaturated fatty acids
(C18:2 n6 = 11.88%; C18:3 n3 = 0.14%). The fatty acid com-
position of the dietary oil used was determined by gas chro-
matography (Sundram, Pathmanathan, Wong, & Baskaran,
1997a). Additionally, a dietary cholesterol of 0.15% was added
in the diet formulation. In rabbits, lesion morphology is al-
tered by the percentage of cholesterol added to the diet and
the feeding duration (Bocan et al., 1993; Kolodgie et al., 1996;
Finking & Hanke, 1997). Short feeding duration with high per-
centage of cholesterol of more than 2% may cause hypercho-
Table 1 – Composition of formulated rabbit atherogenic
diet.
Ingredients g/kg diet % en
Casein 250.0 25.51
Corn starch 200.0 20.41
Dextrose 193.0 19.64
Dietary fat 150.0 34.44
Cellulose 150.0
Mineral mix 40.0
Vitamin mix 10.0
Choline bitartrate 2.5
DL-Methionine 3.0
Cholesterol 1.5
Table 2 – Composition of palm vitamin E.
Vitamin E
isomer
Content
(mg/kg dietary fat)
Percentage (%)
a-Tocopherol 262.5 21
a-Tocotrienol 325.0 26
c-Tocotrienol 500.0 40
d-Tocotrienol 162.5 13
Total 1250.0 100
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which originate frommacrophages. In contrast, a diet supple-
mented with a high fat, low dietary cholesterol content and
long feeding duration may cause atherosclerotic lesions that
are rich in smooth muscle cells and contain cholesterol
deposits leading to atherosclerotic lesions more similar to
those of humans (Kolodgie et al., 1996). Kritchevsky and
Tepper (1965) stated that saturated fats were more athero-
genic in rabbits than unsaturated fats and the atherogenic effect
can be further enhanced by the presence of dietary choles-
terol. Besides that, Yanni (2004) and Kolodgie et al. (1996) also
justified the usage of low cholesterol to induce atherosclerosis
in rabbits. This is based on evidence that human lesions at
late stage are similar to those seen in rabbits given a diet high
in fat and low in cholesterol for extended periods (Adams,
Miller, Morgan, & Rao, 1982). Additionally, Yanni (2004)
reported highmortality rates in animals supplemented for long
periods with 1–2% cholesterol in their diets. Similar to our
study, Tijburg, Wiseman, Meijer, and Weststrate (1997) also
fed rabbits with a high fat diet containing 35% energy and
0.15% (w/w) of dietary cholesterol. Therefore, although the
standard rabbit model for atherosclerosis usually contains
higher level of added cholesterol (0.5–1%), the low level of
cholesterol used in our study is justified and plaque formation
in these animals was primarily driven by the saturated fat
content of the diet and not cholesterol. The diet was designed
to mimic the human diet where a higher fat content predom-
inates and is recognised as the contributing factor to athero-
sclerosis plaque formation (Sundram, Ismail, Hayes,
Jeyamalar, & Pathmanathan, 1997b).
Palm vitamin E rich in tocotrienols was supplied by Sime
Darby Bioganic Sdn. Bhd. (previously known as Golden Hope
Bioganic, Selangor, Malaysia). The tocol content of the palm
vitamin E used is shown in Table 2. The final vitamin E con-
tent in the VIT E pellet diet was 125 mg/kg, whereas the base
pellet diet (fed to CTR and OPP groups) contained 50 mg/kg
diet, primarily from the oil used in the diet formulation. Oil
palm phenolics were supplemented to the OPP and VIT
E + OPP groups as drinking fluid containing total phenolics
at 1500 mg GAE/L. The preparation and characterisation of
the composition of oil palm phenolics have been previously
described (Sambanthamurthi et al., 2011a), with the phenolic
content of oil palm phenolics shown in Table 3. On a dry
weight basis, the phenolic content in oil palm vegetationliquor ranged from 1.38% to 2.43% and the remaining 98%
were fruit sugars, soluble fibers, organic acids and water-sol-
uble vitamins, etc. (Sambanthamurthi et al., 2011a). During
the feeding duration, animals were monitored for their food
and fluid intakes and weight changes. The consumption of
oil palm phenolics in the OPP and VIT E + OPP groups was
carefully measured over a continuous 11 day duration and
was found to be approximately 150 mg GAE/day/animal.
At the end of the feeding trial, all animals were exsangui-
nated via cardiac puncture. Prior to exsanguination, the ani-
mals were fasted overnight and then anaesthetised with a
mixture of ketamine (100 mg/ml) and xylazil (20 mg/ml) at
0.2 ml/kg body weight. Thirty millilitres of blood were drawn
by cardiac puncture. Plasma was prepared by centrifugation
at 3000g for 20 min and stored at 80 C until analysis. The
animals were then overdosed with sodium pentobarbital be-
fore autopsy. Various organs of interest such as liver, heart,
lungs and kidneys were harvested. The entire aorta system
was carefully traced, dissected and cleaned of adherent
adventitial tissues. The aorta was then cut open longitudi-
nally and preserved in 10% formalin.
2.2. Plasma lipid analysis
Plasma lipids (TC, TG, LDL-C, HDL-C) were analysed using
enzymatic assay kits (Roche Diagnostics GmbH, Mannheim,
Germany), as per manufacturer’s protocol on the clinical
chemistry autoanalyser, Roche/Hitachi 902.
2.3. Plasma antioxidant status
Plasma antioxidant statuswasmeasured by twomethods, the
2,20-azinobis (3-ethylbenzothiazoline) 6-sulphonic acid radi-
cal cation (ABTSÆ+) decolorisation and ferric reducing ability
of plasma (FRAP) assays.
The ability of plasma from rabbits to scavenge the ABTSÆ+
cation was measured using the method of Re et al. (1999),
as adapted by Balasundram (2006). The intensely coloured
ABTSÆ+ is relatively stable, but in the presence of an antioxi-
dant, it is readily reduced to a colourless ABTSÆ2. The loss
of absorbance at 734 nm after 6 min is taken as a measure-
ment of the ABTSÆ+ scavenging activity. Standard ABTSÆ+ scav-
enging curve was constructed using 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox), and the
ABTSÆ+ scavenging capacity of the plasma is reported in terms
of mg Trolox equivalents/mL (mg TE/mL).
The ferric reducing antioxidant power (FRAP) of plasma
was determined using the method of Firuzi, Lacanna,
Petrucci, Marrosu, and Saso (2005), as adapted by Balasundram
Table 3 – Composition of oil palm phenolics.
Phenolic compound (mg/kg)
Protocatechuic acid 900
p-Hydroxybenzoic acid 10 500
Caffeoylshikimic acid (total of three isomers) 16 200
Total phenolics (based on Folin Ciocalteau assay) 38 400
Figures are on a dry weight basis (mg of each major phenolic component for every kg of freeze-dried oil palm phenolics) and represent
triplicate analyses of oil palm phenolic samples processed from the aqueous by-products obtained from the Malaysian palm oil mills in Labu,
Negeri Sembilan, according to the methods described in Sambanthamurthi et al. (2011a). Total phenolics assessed based on the Folin Cio-
calteau assay comprise major and mostly unidentified minor phenolics. Only the major phenolics in oil palm phenolics are shown in this table.
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plasma, i.e. the ability to reduce a ferric-2,4,6-tripyridyl-S-tri-
azine (Fe3+-TPTZ) ion to a ferrous-2,4,6-tripyridyl-S-triazine
(Fe2+-TPTZ) ion via an electron transfer mechanism (Benzie
& Strain, 1996). This reduction results in the production of
an intensely blue coloured reduced complex, with a maxi-
mum absorption at 593 nm (Benzie & Strain, 1996).
2.4. Determination of lesion area
After removal of adventitial tissues and fat, aorta was stained
in a 1% (w/v) solution of oil red O in 60% (v/v) triethyl phos-
phate for 20 min and then destained with 60% (v/v) triethyl
phosphate for 30 min (Paigen, Morrow, Holmes, Mitchell, &
Williams, 1987). Plaque area was quantified by using a digital
image analysis software (i-SolutionDT, i-MTechnology, Dusan,
Daejeon, Korea) and expressed as percentage of the total aor-
tic surface. Lesionswere categorised according to Kritchevsky,
Tepper, and Story (1978):
1. Fibrous plaques: Raised nodular lesions, continuous,
intense red, white hard and visible to naked eyes
2. Fatty plaques: Raised distinct lesions, intensely stained red
3. Fatty streaks: Lipid accumulation, stained light red
4. Lesion free: No plaques or streaks
2.5. Histological assessments
For histological assessments of the segments/plaques, the
aorta was fixed in formalin solution and paraffin-embedded.
The formalin-fixed paraffin-embedded blocks were sectioned
(5 lm per section) using a Jung Multicut 2045 rotary micro-
tome, transferred onto glass slides and stained with hema-
toxylin and eosin (H&E) (Kierman, 1990). The slides were
assessed blindly and independently by two experienced
pathologists using the Nikon Eclipse 50i photomicroscope.
2.6. Statistical analyses
All data were analysed using the one-way analysis of variance
(ANOVA) followed by LSD multiple comparisons (protected
LSD) to test differences between dietary treatments. Differ-
ences were considered statistically significant at p < 0.05. Sta-
tistical analysis was performed using the Statistical Package
for Social Science (SPSS).3. Results
3.1. Body and organ weights
Mean body weights of the rabbits, prior to and at the end of
the study, were not significantly different (p > 0.05) between
dietary treatments after 100 days of dietary intervention (Ta-
ble 4). This indicates that the high-fat atherogenic diet used
in this study did not adversely impact the normal growth of
the animals. At sacrifice, organ weights namely liver, heart,
lungs and kidneys were not significantly different (p > 0.05)
between treatment groups (VIT E, OPP, VIT E + OPP) when
compared to the CTR group (Table 4).
3.2. Plasma lipid levels
The analysis of plasma lipid profiles (TC, TG, LDL-C and HDL-
C) showed that rabbits in the OPP and VIT E + OPP groups did
not exhibit significant differences compared to the CTR and
VIT E groups, although the HDL-C level was observed to be
slightly higher (but not statistically significant (p > 0.05).
3.3. Plasma antioxidant capacity
The antioxidant capacity of the rabbit plasma was deter-
mined by both the ABTSÆ+ decolourisation assay and the FRAP
assay. Although the FRAP results for the OPP group
(12.32 ± 5.69 mg TE/mL) and the VIT E + OPP group
(10.53 ± 4.84 mg TE/mL) were comparatively higher than that
of the CTR group (7.18 ± 2.66 mg TE/mL), the differences were
not statistically significant (p > 0.05) (Table 4). Similarly, the
plasma ABTSÆ+ scavenging capacity among all the four treat-
ments was not significantly different (p > 0.05).
3.4. Atherosclerosis development
All the rabbits used in this study developed atherosclerotic le-
sions after being fed the atherogenic diet for 100 days (Ta-
ble 5). The CTR group had a significantly higher (p < 0.05)
fibrous plaque score (8.90 ± 5 .41) compared to the other three
groups (VIT E, OPP and VIT E + OPP) (Fig. 1A). In the VIT
E + OPP group, all animals did not show any development of
fibrous plaques compared to the CTR, VIT E and OPP groups
which developed these plaques. Fatty plaques were signifi-
cantly higher (p < 0.05) in both the CTR and VIT E groups com-
pared to the OPP and VIT E + OPP groups (Fig. 1B). In addition,
Table 4 – Animal body weights, organ weights, plasma lipid profiles and plasma antioxidant profiles after 100 days of
treatment.
Parameter CTR VIT E OPP VIT E + OPP
Mean SD Mean SD Mean SD Mean SD
Body weights (g)
Initial 1871.43 48.80 1857.14 78.68 1860.97 214.12 1822.27 146.90
Final 2229.43 369.30 2432.37 171.39 2185.87 752.94 2122.47 375.10
Organ weights (g)
Liver 72.63 11.34 61.83 8.71 67.90 12.63 64.46 11.54
Heart 4.11 0.83 4.45 0.60 4.30 0.71 4.15 0.94
Lungs 7.56 1.63 7.20 1.03 8.54 1.57 7.26 1.30
Kidneys 9.60 0.99 10.49 1.59 11.72 1.78 9.65 2.42
Plasma lipid profiles (mmol/L)
TC 19.78 3.14 17.91 4.67 18.01 4.18 19.11 1.76
TG 2.33 1.42 1.95 1.34 0.18 0.32 0.87 0.20
LDL-C 14.80 2.73 13.21 4.50 13.60 4.32 14.66 2.05
HDL-C 3.90 0.96 3.81 1.10 4.03 0.56 4.05 0.61
Plasma antioxidant capacity (TE/mL)
ABTSÆ+ 74.95 6.75 77.14 4.88 75.73 4.84 76.39 5.12
FRAP 7.18 2.66 6.17 1.15 12.32 5.69 10.53 4.84
(Mean values and standard deviations, n = 8).
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the VIT E + OPP treatment. Fatty streak incidence was highest
(23.02 ± 7.75) in the VIT E treated animals followed by the CTR
group (Fig. 1C).
OPP and VIT E + OPP groups had significantly lower
(p < 0.05) development of fatty streaks compared to the CTR
and VIT E groups. Lesion free area denoting the total area that
was not alteredmorphologically (i.e. free of fatty streaks, fatty
and fibrous plaques), was significantly higher (p < 0.05) follow-
ing the VIT E + OPP and OPP diets compared to the VIT E and
CTR diets (Fig. 1D). This observation suggests protective ef-
fects of the OPP and VIT E + OPP treatments against the occur-
rence of atherosclerosis.
The histological assessments generally agreed with the
above observations with regards to the extent of atheroma-
tous plaque formation. The main microscopic lesions ob-Table 5 – Inhibition of the development of aortic lesions in rab
Parameter CTR VIT E
Mean SD Mean
Fibrous plaque 8.90 5.41a,b,c 2.88
Fatty plaque 9.32 2.48a,b 10.66
Fatty streak§ 14.41 5.25a,b 23.02
Lesion free|| 67.20 7.67a,b 63.35
Total lesion area 99.83 0.28 99.91
Total aorta area** (mm2) 1410.28 121.80 1515.84
* Values are percentages of total aorta area (Mean values and standard de
 Raised nodular lesions, continuous, intense red, white hard and visible t
 Raised distinct lesions, intensely stained red.
§ Lipid accumulation, stained light red.
|| Healthy intima.
** Percentage (%) of aortic area as fibrous plaques, fatty plaques and fatty
a,b,c Mean values with the same superscript letters are significantly differeserved in the CTR group included formation of fibrous cap
and lipid core with disorganised layers of foamymacrophages
deposited in the tunica intima which directly increased its
thickness. The infiltration of inflammatory cells, mainly
mononuclear, was evident in this group. At certain areas,
the tunica intima was sloughed off leaving the tunica media
exposed. Invasion of foam cells was observed in the begin-
ning of the tunica media. The oil palm phenolics treated ani-
mals showed smooth muscle proliferation, intimal fibrosis
and extracellular lipid but there was no evidence of lipid core
or necrosis. There was lesser degree of foam cell formation.
The VIT E group generally exhibited well-formed lipid core fi-
brous cap atheroma distinguished by fibrous cap, free of
inflammatory cells. In contrast, pathological lesions were
far less discernible in the VIT E + OPP group where fewer foam
cells and mild thickening of the tunica intima were observed.bits fed an atherogenic diet.*
OPP VIT E + OPP
SD Mean SD Mean SD
2.01a 1.48 4.45b 0.00c 0.00
4.45c,d 3.51 4.52a,c 0.72 1.82b,d
7.75a,c,d 8.45 2.55c 6.21 4.36b,d
8.04c,d 86.38 8.12a,c 92.93 5.13b,d
0.02 99.82 0.12 99.86 0.09
148.62 1486.85 135.36 1281.05 127.13
viations, n = 8).
o naked eyes.
streaks.
nt from each other (p < 0.05).
Fig. 1 – Photographs of aortic lesions in rabbits fed an atherogenic diet in different groups (A) CTR, (B) VIT E, (C) OPP and (D)
VIT E + OPP.
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These descriptions refer to the most characteristic lesions
in the various groups and are qualitative assessments.
4. Discussion
The protective effect of various plant products against chronic
diseases has been attributed to the various antioxidants con-
tained in them, especially their synergistic effects (Steinberg
et al., 1989; Steinberg, 1991). Zawistowski, Kopec, and Kitts
(2009), Kwok et al. (2010, 2013), Thilakarathnaa, Wang,
Vasantha Rupasinghea, and Ghanam (2012) and Asgary et al.
(2013) have reported the roles of black rice extract, hawthorn,
apple peel extracts and black cumin respectively as functional
foods in preventing hypercholesterolaemia and/or atheroscle-
rosis development in various animal models. In addition,
vitamin E (Williams, Motteram, Sharp, & Gallagher, 1992)
and phenolic compounds (Yamakoshi, Kataoka, Koga, &
Ariga, 1999) have been documented to inhibit the develop-
ment of aortic lesions in rabbits. Results obtained from the
present study are consistent with these previous findings. A
mixture containing both water-soluble and lipid-soluble anti-
oxidants is able to quench free radicals in both aqueous and
lipid phases (Chen & Tappel, 1996). Murakami, Yamaguchi,
Takamura, and Matoba (2003) showed that a combination of
quercetin or catechins plus a-tocopherol exhibited signifi-
cantly higher activity than the sum of the individual activities
using the liposome oxidation method. The cholesterol-rich
atherogenic diet that was fed to the rabbits in this study did
not result in any significant differences in their lipid profiles
(p > 0.05). This was not entirely surprising since the animals
were all subjected to the high cholesterol atherogenic diet
that rendered them all hypercholesterolaemic. The resultinghypercholesterolaemia triggered atherogenic tendencies
within the 100 days of the feeding duration. Despite the in-
duced hypercholesterolaemia, the overall atherogenic out-
comes were significantly modulated by the type of
antioxidant added to the diet of these animals.
Frankel, Waterhouse, and Kinsella (1993), Vinson et al.
(1999) and Pietta (2000), reported that many flavonoids and re-
lated polyphenols are actually better antioxidants than vita-
mins. The oil palm is also rich in phenolic compounds, as
reported by Sambanthamurthi et al. (2011a). To our knowl-
edge, no studies have investigated the effects of oil palm
phenolics in combination with other compounds on the
development of atherosclerosis although a preliminary study
in rabbits on the effects of oil palm phenolics at low and high
doses was reported by Sambanthamurthi et al. (2011b). In
their study, all rabbits were fed a high-fat atherogenic diet
and provided either distilled water (control), oil palm pheno-
lics at 500 mg/L GAE, or oil palm phenolics at 1000 mg/L
GAE, as their drinking fluids. The results indicated a net pro-
tection against the development and progression of athero-
sclerosis in a dose-dependent manner.
Ross (1993) and Tedgui and Mallat (2006) stated that the
first step of atherogenesis is the progression of the accumula-
tion of foam cells resulting in the formation of fatty streaks,
which are the earliest observable abnormality of the vessel
wall. These fatty streaks will gradually progress to intermedi-
ate, fatty plaques and ultimately evolve into fibrous plaques.
Sambanthamurthi et al. (2011b) reported that control rabbits
developed extensive aortic fibrous and fatty plaques as well
as fatty streaks. On the other hand, animals given the same
atherogenic diet but supplemented with oil palm phenolics
had significantly reduced fatty plaques and fatty streaks.
However, not much is known about the synergistic effects of
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Thus, in the present study, we examined the synergistic ef-
fects when palm vitamin E and oil palm phenolics were com-
bined and provided as a supplement to the rabbits. According
to Upaganlawar, Gandhi, and Balaraman (2009), several stud-
ies have shown that antioxidants are uniquely different from
one another and work synergistically and more effectively
when they are used in combination. Our current observations
are also in agreement with Stocker and O’Halloran (2004) who
reported that dealcoholised red or white wine which contains
polyphenolic compounds was capable of synergising with
vitamin E and decreasing atherosclerosis in apolipoprotein
E-deficient (Eo) mice.
From the analysis of plasma lipid profiles (TC, TG, LDL-C
and HDL-C) in this present study, rabbits in the OPP group
did not exhibit significant differences although the HDL-C le-
vel was observed to be slightly higher (but not statistically sig-
nificant (p > 0.05)) compared to the CTR and VIT E groups.
However, these animals had significantly reduced incidence
of atherosclerosis (i.e. less fibrous and fatty plaques as well
as fatty streaks) (p < 0.05) when compared to the CTR and
VIT E groups. Similar observations were also made by Wang
et al. (2005), who reported that a 12 week supplementation
of dealcoholised red wine containing resveratrol suppressed
atherosclerosis in hypercholesterolaemic rabbits and con-
cluded that the phytochemicals present in red wine could
suppress atherosclerosis without affecting plasma lipid lev-
els. Fuhrman, Volkova, Coleman, and Aviram (2005) also re-
ported that fresh grape powder attenuated atherosclerotic
development in apolipoprotein Eo mice without affecting
their lipid profiles. Similarly, although no changes were seen
in plasma LDL-C or HDL-C upon feeding of red wine to Eo
mice, reduced progression of lesions was reported by Hayek
et al. (1997).
In the present study, rabbits in the VIT E + OPP group also
did not exhibit significant changes (p > 0.05) in their plasma li-
pid profiles (TC, TG, LDL-C and HDL-C), although the HDL-C
level was observed to be slightly higher (not statistically sig-
nificant (p > 0.05)) compared to the CTR and VIT E groups. This
was similar to the rabbits in the OPP group, except that these
animals from the VIT E + OPP group had no fibrous plaques
and also significantly reduced incidence of atherosclerosis
(i.e. less fatty streaks and plaques) compared to the CTR
and VIT E groups (p < 0.05). This suggests that the atheropro-
tective effects of oil palm phenolics might be contributed by
other mechanisms instead of influencing lipid and antioxi-
dant profiles.
One possible mechanism by which oil palm phenolics
could reduce atherosclerotic lesions is through its anti-
inflammatory effects. Cytokines play a significant role in
mediating the inflammatory response in atherosclerosis. Ath-
erosclerosis is generally associated with cytokines that pro-
mote a Type 1 helper T-cell (Th1) cellular immune response
rather than a Type 2 helper T-cell (Th2) humoral immune re-
sponse. The modulation of the Th1/Th2 axis toward the latter
may thus be atheroprotective. Leow, Sekaran, Sundram, Tan,
and Sambanthamurthi (2013), showed that oil palm phenolics
were able to attenuate antigen presentation and processing in
the spleens of mice given an atherogenic diet. In addition, oil
palm phenolics also modulated the Th1/Th2 axis of theimmune system towards the latter, thus suggesting that oil
palm phenolics reduce atherosclerosis via its anti-inflamma-
tory actions. This mechanism may thus help explain the
changes observed in the current study. Leow et al. (2013) also
showed that in addition to its anti-inflammatory effects, oil
palm phenolics restored the antioxidant capacity of mice
fed the atherogenic diet. Further investigations to discover
other possible/probable mechanisms by which oil palm phen-
olics reduce atherosclerosis are warranted. Thus, VIT E + OPP
resulted in significant reduction (p < 0.05) in the development
of atherosclerotic lesions compared to animals given either
vitamin E alone or oil palm phenolics alone. In a similar study,
Xu et al. (1998) reported that reduction of oxidative stress
in vivo by catechin and vitamin E in their hamster study could
prevent fatty streak accumulation in the aorta. The effect of
oil palm phenolics in inhibiting the formation of fibrous pla-
ques in the present study was evident in both the OPP and
VIT E + OPP groups compared to the CTR and VIT E groups,
suggesting that oil palm phenolics may potentially inhibit
atherosclerosis. Similarly, other phenolic compounds demon-
strated this property as well. For example, pomegranate juice
(Kaplan et al., 2001), grape extract (Auger et al., 2004), as well
as red wine, dealcoholised wine and wine polyphenols
(Stocker & O’Halloran, 2004; Manach, Mazur, & Scalbert,
2005) were found to reduce atherosclerotic lesions when fed
to various animal models. Although the VIT E group had high-
er incidence of fatty plaques, this group showed a significant
reduction in fibrous plaque formation, indicating that VIT E
arrested the progression of fatty plaques to fibrous plaques.
Histopathological examination revealed massive destruc-
tion of the tunica intima in the CTR group indicating endothe-
lial activation (De Caterina, Liao, & Libby, 2000). These fibrous
caps were formed due to proliferation and migration of
smooth muscles and connective tissue deposition. The for-
mation of lipid core and form cells was reduced after admin-
istration of vitamin E and oil palm phenolics individually and
especially in combination. These results suggest the great po-
tential of these phytonutrients in mitigating atherosclerosis
even when on high fat diets.
In this study, plasma antioxidant capacity was also mea-
sured by two different methods, i.e. the ABTSÆ+ and FRAP as-
says. The use of two methods for measurement of
antioxidant activity was based on the suggestions by Frankel
and Meyer (2000) as well as Verhagen et al. (2003), on the need
to evaluate antioxidant activity by using different methods.
Additionally, these two methods are recommended for
measuring antioxidant capacity due to their rapidity of
analysis, ease of use and high sensitivity (Maisuthisakul,
Pongsawatmanit, & Gordon, 2007).
Results obtained from theABTSÆ+ scavenging assay, showed
no significant differences in all the fourgroups tested (p > 0.05).
Results from the FRAP assay also appeared to be not signifi-
cantly different (p > 0.05), although the plasma antioxidant
capacity values of the OPP and VIT E + OPP groups appeared
higher than that of the CTR group. The different results ob-
tained from the ABTSÆ+ and FRAP methods could be due to
the different mechanisms of reactions involved. The ABTSÆ+
method is a diammonium salt radical cation scavenging assay,
whereas the FRAP method is a ferric reducing power assay. In
addition, the antioxidants in plasma consist of a complex cas-
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may have evoked different responses to both the ABTSÆ+ and
FRAP measurements (Jimenez-Escrig, Dragsted, Daneshvar,
Pulido, & Saura-Calixto, 2003). Although not significant, the
OPP and OPP + VIT E groups had higher plasma antioxidant
capacity based on the FRAP assay. Previous in vitro studies
had confirmed potent antioxidant potential of oil palm pheno-
lics (Sambanthamurthi et al., 2011a). It has also been reported
that phenolic compounds exert their positive impact in the gut
itself (Kemperman, Bolca, Roger, &Vaughan, 2010). The antiox-
idant activities of phenolic compounds increase with the de-
gree of hydroxylation (Rice-Evans, Miller, & Paganga, 1996).
Phenolics usually exist in the conjugated form with sugars
andothermoieties. Theconjugation reactionsoccurvia thehy-
droxyl groups and hence reduce the degree of hydroxylation
and thus antioxidant potential of the phenolic compounds.
However oil palmphenolics existmainly as free phenolic acids
as they are obtained from the oil palm milling process where
sterilisation of the fruits results in hydrolysis of conjugated
phenolics and the release of unconjugated phenolic acids. Oil
palm phenolics comprise three isomers of caffeoylshikimic
acid, followed by p-hydroxybenzoic and protocatechuic acids
as the major phenolic compounds. Caffeoylshikimic acid has
four hydroxyl groups, and this would account for the potent
in vitro antioxidant activity of oil palm phenolics. The other
phenolic acidswould also be expected to contribute to the anti-
oxidant activity observed. Working together, these phenolic
acids may have a synergistic effect with each other as well as
with the vitamin E mixture comprising mainly tocotrienols (a,
b and c forms) and a-tocopherol. It is also highly likely that
thephenolic acids andvitamin E in combination effect positive
outcomes via mechanisms other than antioxidative routes.
Thus, the anti-atherogenic effects conferred by oil palm
phenolics and vitamin E in the present study may be ex-
plained by the vast mixture of phenolic acids, together with
the tocotrienols and tocopherols present. These anti-athero-
genic mechanisms of oil palm phenolics should be investi-
gated in future studies.
5. Conclusion
The effects of oil palm phenolics (OPPs) either on their own or
in combination with vitamin E (VIT E + OPP) in inhibiting ath-
erosclerosis were investigated, and a superior inhibitory ef-
fect on the development of atherosclerotic lesions was
observed in both the OPP and VIT E + OPP groups compared
to the CTR and VIT E groups. These findings suggest a poten-
tial area for the application of oil palm vitamin E and oil palm
phenolics as antioxidants in modulating cardiovascular risk
factors, which merit further research attention. The effects
shown by this combination of bioactives present in the oil
palm also constitute an important factor in the formulation
of functional foods and in the choice of a diet which uses
the oil palm as a food source.
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